| 1 |
Kommoss FKF, Mar LM, Howitt BE, Hanley K, Turashvilli G, Buslei R, Irving JA, Dickson BC, Koelsche C, Sinn HP, Schirmacher P, von Deimling A, Chiang S, McCluggage WG, Croce S, Stewart CJR, Lee CH. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker. Mod Pathol 2023;36:100044. [PMID: 36788095 DOI: 10.1016/j.modpat.2022.100044] [Reference Citation Analysis]
|
| 2 |
Dermawan JK, Dashti N, Chiang S, Turashvili G, Dickson BC, Ellenson LH, Kirchner M, Stenzinger A, Mechtersheimer G, Agaimy A, Antonescu CR. Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners. Genes Chromosomes Cancer 2023;62:152-60. [PMID: 36445224 DOI: 10.1002/gcc.23109] [Reference Citation Analysis]
|
| 3 |
Niu S, Rivera-Colon G, Lucas E. Aggressive High-grade Uterine Sarcoma Harboring MEIS1-NCOA2 Fusion and Amplification of Multiple 12q13-15 Genes: A Case Report With Morphologic, Immunohistochemical, and Molecular Analysis. Int J Gynecol Pathol 2023. [PMID: 36811835 DOI: 10.1097/PGP.0000000000000937] [Reference Citation Analysis]
|
| 4 |
Moghaddam PA, Young RH, Ismiil ND, Bennett JA, Oliva E. An Unusual Endometrial Stromal Neoplasm With JAZF1-BCORL1 Rearrangement. Int J Gynecol Pathol 2023. [PMID: 36811828 DOI: 10.1097/PGP.0000000000000941] [Reference Citation Analysis]
|
| 5 |
Hasegawa C, Washimi K, Hiroshima Y, Kasajima R, Kikuchi K, Notomi T, Kato H, Hiruma T, Sato S, Okubo Y, Yoshioka E, Ono K, Miyagi Y, Yokose T. Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling. Diagn Pathol 2023;18:5. [PMID: 36639698 DOI: 10.1186/s13000-022-01279-4] [Reference Citation Analysis]
|
| 6 |
Zhang T, Feng RL, Yin SF, Feng WB, Yin ZY, Wang H, Ke CX. Case report: High-grade endometrial stromal sarcoma with adrenal glands metastases: An unreported site of metastasis. Front Oncol 2022;12:1058700. [PMID: 36505854 DOI: 10.3389/fonc.2022.1058700] [Reference Citation Analysis]
|
| 7 |
Hasegawa C, Washimi K, Hiroshima Y, Kasajima R, Kikuchi K, Notomi T, Kato H, Hiruma T, Sato S, Okubo Y, Yoshioka E, Ono K, Miyagi Y, Yokose T. Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genome profiling.. [DOI: 10.21203/rs.3.rs-1995945/v1] [Reference Citation Analysis]
|
| 8 |
Rodriguez Pena MDC, Mubeen A, Harada S, Prieto Granada CN. An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1. Int J Gynecol Pathol 2022. [PMID: 35838627 DOI: 10.1097/PGP.0000000000000894] [Reference Citation Analysis]
|
| 9 |
Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Am J Surg Pathol 2022. [PMID: 35575789 DOI: 10.1097/PAS.0000000000001915] [Reference Citation Analysis]
|
| 10 |
Kim Y, Kim D, Sung WJ, Hong J. High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies. Front Immunol 2022;13:837004. [PMID: 35242139 DOI: 10.3389/fimmu.2022.837004] [Reference Citation Analysis]
|
| 11 |
Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications. Am J Surg Pathol 2022. [PMID: 35499168 DOI: 10.1097/PAS.0000000000001909] [Reference Citation Analysis]
|
| 12 |
Kertowidjojo EC, Bennett JA. Update on Uterine Mesenchymal Neoplasms. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 13 |
Wei Q, Mackinnon AC, Siegal GP, Harada S. The diagnostic utility of RNA-based fusion panel testing ordered by pathologists in challenging cases. Annals of Diagnostic Pathology 2022. [DOI: 10.1016/j.anndiagpath.2022.151957] [Reference Citation Analysis]
|
| 14 |
Driva TS, Schatz C, Sobočan M, Haybaeck J. The Role of mTOR and eIF Signaling in Benign Endometrial Diseases. Int J Mol Sci 2022;23:3416. [PMID: 35408777 DOI: 10.3390/ijms23073416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
